Mylan Institutional LLC Recall: Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized pow
Mylan Institutional LLC Recall: Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized pow is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Mylan Institutional LLC; Product: Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: My
| Recalling firm | Mylan Institutional LLC |
|---|---|
| Product | Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5. |
| Reason for recall | Presence of Particulate Matter |
| Classification | Class I (most serious — reasonable probability of serious health consequences or death) |
| Status | Terminated |
| Distribution | Nationwide and Puerto Rico |
| Recall initiated | 20150323 |
| Recall number | D-1333-2015 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →